eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
4/2019
vol. 11
 
Share:
Share:
more
 
 
abstract:
Review paper

Malignant pleural effusion

Anna Zasowska-Nowak
1

1.
Zakład Medycyny Paliatywnej, Katedra Onkologii, Uniwersytet Medyczny w Łodzi
Medycyna Paliatywna 2019; 11(4): 149–155
Online publish date: 2020/03/04
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Malignant pleural effusion is a common problem in palliative care, observed in 15% of cancer patients, mainly in the course of lung cancer in men, breast cancer in women, and mesothelioma. This type of cancer complication is related to poor prognosis. Excessive fluid accumulation in the pleural cavity is caused by primary thoracic tumours or metastatic lesions in the chest and/or lymph nodes with destruction of lymphatic vessels, and also by cancer complications such as pneumonia or pulmonary thromboembolism. Relief of dyspnoea is the main goal in palliative care patients with malignant pleural effusion. Therapeutic thoracentesis is a treatment of choice; nevertheless, in some clinical situations more invasive procedures can be considered.
keywords:

hydrothorax, malignant pleural effusion, cancer

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe